Abstract

Nowadays, bacteriophages are increasingly considered as an alternative treatment for a variety of bacterial infections in cases where classical antibiotics have become ineffective. However, characterizing the host specificity of phages remains a labor- and time-intensive process. In order to alleviate this burden, we have developed a new machine-learning-based pipeline to predict bacteriophage hosts based on annotated receptor-binding protein (RBP) sequence data. We focus on predicting bacterial hosts from the ESKAPE group, Escherichia coli, Salmonella enterica and Clostridium difficile. We compare the performance of our predictive model with that of the widely used Basic Local Alignment Search Tool (BLAST). Our best-performing predictive model reaches Precision-Recall Area Under the Curve (PR-AUC) scores between 73.6 and 93.8% for different levels of sequence similarity in the collected data. Our model reaches a performance comparable to that of BLASTp when sequence similarity in the data is high and starts outperforming BLASTp when sequence similarity drops below 75%. Therefore, our machine learning methods can be especially useful in settings in which sequence similarity to other known sequences is low. Predicting the hosts of novel metagenomic RBP sequences could extend our toolbox to tune the host spectrum of phages or phage tail-like bacteriocins by swapping RBPs.

Highlights

  • Nowadays, bacteriophages are increasingly considered as an alternative treatment for a variety of bacterial infections in cases where classical antibiotics have become ineffective

  • We show that our approach outperforms predictions by BLASTp when sequence similarity to other known sequences in the database drops below 75%

  • receptor-binding protein (RBP) sequences related to E. coli represent a large proportion of the database (n = 324), followed by sequences related to K. pneumoniae (n = 176) and P. aeruginosa (n = 117)

Read more

Summary

Introduction

Bacteriophages are increasingly considered as an alternative treatment for a variety of bacterial infections in cases where classical antibiotics have become ineffective. There is an increasing interest in narrow-spectrum ­antibiotics[2] Both bacteriophages and phage tail-like bacteriocins (PTLBs, called tailocins) are antibacterials with a narrow specificity that fulfill this need. RBPs recognize specific bacterial receptors on the cell surface such as polysaccharides (capsule, biofilm matrix, lipopolysaccharide), proteins, pili or f­lagella[5]. This initial recognition subsequently leads to infection of the bacterium by a phage or the depolarization of its membrane by a ­PTLB10. Engineering tools have been developed to modulate the host range of well-known phages and PTLBs by swapping or modifying their ­RBPs5,6,25–27 These tools demonstrate the potential of RBP engineering towards novel antibacterials with narrow and tunable host specificity

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call